UCSF

Topics and Expertise: pharmacodynamics

Aweeka study details impact of HIV drugs on malaria treatment in children

Sub-Saharan Africa is home to a billion people and to overlapping health burdens, including the world’s highest rates of both malaria and HIV infection.

Giacomini to lead largest study of genetic, ethnic differences in effectiveness of leading diabetes drug

In people with type 2 diabetes, the body is less able to use the hormone insulin to regulate blood sugar. The disease affects 350 million patients globally—including 29 million in the United States, where it is the leading cause of blindness, kidney failure, and non-accident-related amputations.

Yang study demonstrates simulator to study antibiotic dosing against biofilms

Nearly every human bacterial infection—including some of the most serious, life threatening, and costly to treat—can take the form of a biofilm, in which bacteria aggregate into structured communities that enclose themselves within a secreted slime.

Aweeka co-leads new study of drugs to prevent malaria in young children, pregnant women

Francesca Aweeka, PharmD, a faculty member in the School’s Department of Clinical Pharmacy, will co-lead a new five-year, $3.4 million study funded by the National Institutes of Health (NIH) to address one of the world’s most vexing health problems—preventing malaria, especially in the most...

Jaekyu Shin, PharmD, MS

Professor

I teach and precept pharmacy students and work with underserved populations at Zuckerberg San Francisco General Hospital. My research focuses on the clinical application of cardiovascular pharmacogenetic tests and pharmacoepidemiology.

Janel Long-Boyle, PharmD

Professor of Clinical Pharmacy

I am a translational scientist with research interests that include pediatric cancer therapeutics, pharmacokinetics, pharmacodynamics, pharmacogenomics, and clinical trial design. The majority of my research is focused around the chemotherapeutic and immunosuppressive agents used in the...

Brian Alldredge, PharmD

Vice Provost-Academic Affairs

My clinical practice and research focus on the drug treatment of epilepsy and the genetic, behavioral, and environmental factors that influence drug response.

Rada Savic, PhD

Professor

I investigate the causes of variations in clinical outcomes, using computational methods. My goal is to determine the optimal dosage, timing, and duration of therapeutic regimens. Ultimately, I want to develop precise, personalized treatments.

Leslie Benet, PhD

Professor

Pages